showed a trendP>0.05
Following estrogen administration, both cell types showed a trend toward recovery (CD4, P>0.05 vs TH group, TH 32.17±3.96, TH+EV 32.35±6.32; CD8, P>0.05 vs TH group, TH 6.33±1.28, TH+EV 7.43±1.41).
Following estrogen administration, both cell types showed a trend toward recovery (CD4, P>0.05 vs TH group, TH 32.17±3.96, TH+EV 32.35±6.32; CD8, P>0.05 vs TH group, TH 6.33±1.28, TH+EV 7.43±1.41).